Mitral regurgitation and cardiac resynchronization therapy: How long and what should we expect?

Europace

Volumn 13, Issue 12, 2011, Pages 1801-1802

  Cabrera Bueno, Fernando ^a   Molina Mora, Mara Jos ^a   Alzueta Rodriguez, Francisco Javier ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; HEALTH CARE COST; HEALTH INSURANCE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; OUTPATIENT CARE; PRIORITY JOURNAL;

CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 81855206169     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur273     Document Type: Letter

References (7)

1. Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace 2011;13:829-38.
2. Trichon BH, Felker GM, Shaw LK, Cabell CH, OConnor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-43. (Pubitemid 36263251)
3. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C et al. MitraClip therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76.
4. Cleland J, Daubert J, Erdmann E, Fremantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539-49. (Pubitemid 40517094)
5. Cabrera-Bueno F, Molina-Mora MJ, Alzueta J, Pena-Hernández JL, Jiménez-Navarro MF, Fernández-Pastor J et al. Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy. Eur J Echocardiogr 2010;11:131-7.
6. Richardson M, Freemantle N, Calvert MJ, Cleland J, Tavazzi L on behalf of the CARE-HF study steering committee and investigators. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J 2007;28:1827-34. (Pubitemid 47236653)
7. Cabrera-Bueno F, García-Pinilla JM, Pena-Hernández JL, Jiménez-Navarro MF, Gómez-Doblas JJ, Barrera-Cordero A et al. Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy. Europace 2007;9:757-61. (Pubitemid 47371649)